Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi-Reference-Cited by-同舟云学术

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

Published:2011-12-07 Issue:3 Volume:156 Page:346-353
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Merli Francesco,Luminari Stefano,Ilariucci Fiorella,Petrini Mario,Visco Carlo,Ambrosetti Achille,Stelitano Caterina,Caracciolo Francesco,Di Renzo Nicola,Angrilli Francesco,Carella Angelo M.,Capodanno Isabella,Barbolini Elisa,Galimberti Sara,Federico Massimo

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08958.x/fullpdf

Reference22 articles.

1. Mantle cell lymphoma: a clinicopathologic study of 80 cases;Argatoff;Blood,1997

2. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999

3. A Wilcoxon-type test for trend;Cuzick;Statistics in Medicine,1985

4. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936;van Dongen;Leukemia,2003

5. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network;Dreyling;Blood,2005

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network;Leukemia;2024-04-27

2. Recent advances in genomics and therapeutics in mantle cell lymphoma;Cancer Treatment Reviews;2024-01

3. The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma - a randomized, open-label phase III trial of the European mantle cell lymphoma network;2023-12-28

4. Novel treatment for mantle cell lymphoma – impact of BTK inhibitors and beyond;Leukemia & Lymphoma;2023-10-06

5. Up-Front ASCT Overcomes the Survival Benefit Provided by HDAC-Based Induction Regimens in Mantle Cell Lymphoma: Data from a Real-Life and Long-Term Cohort;Cancers;2023-09-28